Chromosome 8 Polysomy Accounting for MYC Over-Expression in Angiosarcoma Arising as Somatic-Type Malignancy in Metastatic Teratoma. Case Report.
Ana Cristina VargasPeter GrimisonChristopher JoyBernadette GarroneFiona BonarRaha Madadi GhahanTrent DavidsonFiona M MacleanPublished in: International journal of surgical pathology (2021)
MYC over-expression by immunohistochemistry (IHC) is utilised in routine pathology practice as a surrogate marker for MYC amplification, which plays a key oncogenic role in post-irradiation and chronic lymphedema-associated angiosarcoma. We present the case of a 32-year old male, who presented with high-grade angiosarcoma arising in a background of metastatic testicular teratoma. IHC for MYC showed strong nuclear expression in the angiosarcoma cells prompting the consideration of post-irradiation-induced angiosarcoma but our patient did not undergo radiotherapy. Fluorescence in-situ hybridization (FISH) excluded MYC amplification and instead showed Chromosome 8 polysomy, which accounted for the strong MYC IHC expression present, not previously described in the context of germ cell tumours. The occurrence of MYC over-expression due to polysomy illustrates a novel clinical scenario (angiosarcoma arising as somatic malignancy) where strong MYC IHC expression can be found in the absence of underlying amplification or prior radiotherapy exposure.
Keyphrases
- poor prognosis
- transcription factor
- case report
- early stage
- high grade
- small cell lung cancer
- squamous cell carcinoma
- binding protein
- germ cell
- healthcare
- long non coding rna
- gene expression
- risk assessment
- radiation therapy
- locally advanced
- dna methylation
- cell proliferation
- induced apoptosis
- quality improvement
- nucleic acid
- clinical practice
- signaling pathway
- drug induced
- rectal cancer
- stress induced